Optimizing Donor Cellular Dissociation and Subretinal Injection Parameters for Stem Cell‐Based Treatments

Subretinal delivery of stem cell‐derived retinal cells as a strategy to treat retinal degenerative blindness holds great promise. Currently, two clinical trials are underway in which human fetal retinal progenitor cells (RPCs) are being delivered to patients by intravitreal or subretinal injection t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem Cells Transl Med
Hauptverfasser: Scruggs, Brittni A., Jiao, Chunhua, Cranston, Cathryn M., Kaalberg, Emily, Wang, Kai, Russell, Stephen R., Wiley, Luke A., Mullins, Robert F., Stone, Edwin M., Tucker, Budd A., Sohn, Elliott H.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Inc. 2019
Schlagworte:
Standards, Protocols, Policies, and Regulations for Cell‐Based Therapies
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6646699/
https://ncbi.nlm.nih.gov/pubmed/31004408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0210
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge